Tyrosine Phosphorylation of Human Platelet Plasma Membrane Ca-ATPase in Hypertension

Hypertension

Volumn 35, Issue 1, 2000, Pages 103-

  Blankenship, K A ^a   Dawson, C B ^a   Aronoff, G R ^a   Dean, W L ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Ca2+ transporting ATPase; Calcium; Hypertension, essential; Phosphorylation; Platelets

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM);

ARTICLE; CALCIUM CELL LEVEL; CHEMOLUMINESCENCE; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; HEART INFARCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RISK ASSESSMENT; RISK FACTOR; STROKE; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE AGGREGATION;

ADULT; BLOOD PLATELETS; CALCIUM-TRANSPORTING ATPASES; CASE-CONTROL STUDIES; CELL MEMBRANE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PHOSPHORYLATION; RISK FACTORS; THROMBOSIS; TYROSINE;

EID: 0033956859     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.35.1.103     Document Type: Article

References (25)

1. Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight, and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project Research Group. J Chronic Dis. 1978; 31:201-306.
2. Heemskerk JWM, Sage SO. Calcium signaling in platelets and other cells. Platelets (Edinb). 1994; 5:295-316.
3. Andrioli G, Ortolani R, Fontana L, Gaino S, Bellavite P, Lechi C, Minnuz P, Manzato F, Tridente G, Lechi A. Study of platelet adhesion in patients with uncomplicated hypertension. J Hypertens. 1996; 14:11211-11215.
4. 2+] is increased in platelets of spontaneously hypertensive rats and essential hypertensive patients. Clin Sci. 1985; 68:179-184.
5. Erne P, Balli P, Burgisser E, Buhler FR. Correlation of platelet calcium with blood pressure: effect of antihypertensive therapy. N Engl J Med. 1984; 310:1084-1088.
6. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease. Lancet. 1990; 335 (pt I):765-774.
7. 2+ release from platelet internal membranes is regulated by differential phosphorylation. Biochemistry. 1996; 35:6865-6871.
8. 2+-ATPase by cAMP-dependent and tyrosine phosphorylation. J Biol Chem. 1997; 272:15113-15119.
9. Dean WL, Pope JE, Brier ME, Aronoff GR. Platelet calcium transport in hypertension. Hypertension. 1994; 23:31-37.
10. Laemmli UK. Synthesis of T4 phage proteins. Nature. 1970; 227:680-685.
11. Haynes DH. Effects of cyclic nucleotides and protein kinases on platelet calcium homeostasis and mobilization. Platelets (Edinb). 1993; 5:231-242.
12. 2+-ATPase. Cell Calcium. 1989; 10:289-297.
13. Silvestry FE, Sutton MGS. Sustained-release calcium channel antagonists in cardiovascular disease: pharmacology and current therapeutic use. Eur Heart J. 1998; 19(suppl I):I8-I14.
14. Palma-Gamiz JL. High blood pressure and calcium antagonism. Cardiology. 1997; 19(suppl I):I8-I14.
15. Sowers JR, Raman RB, Afonso LC, Bedford-Rice K, Standley PR. Effects of antihypertensive therapy on platelet cytosolic calcium responses to low density lipoprotein cholesterol. J Hum Hypertens. 1996; 10:177-180.
16. Ahn YS, Jy W, Harrington WJ, Shanbaky N, Fernandez LF, Haynes DH. Increased platelet calcium in thrombosis and related disorders and its correction by nifedipine. Thromb Res. 1987; 45:135-143.
17. Ranieri G, Filitti V, Andriani A, Bonfantino MV, Lamontanara G, Cavallo A, Milani M, De Cesaris R. Effects of isradipine sustained release on platelet function and fibrinolysis in essential hypertension with or without other risk factors. Cardiovasc Drug Ther. 1996; 10:119-123.
18. O’Grady J, Kritz H, Schmid P, Pirich C, Sinzinger H. Effect of isradipine on in-vivo platelet function. Thromb Res. 1997; 86:363-371.
19. Gulati S, Khullar M, Sharma BK, Ganguly NK. Platelet calcium pump activity in essential hypertension and their first-degree relatives. Mol Cell Biochem. 1992; 156:37-42.
20. 2+-ATPase. Jpn J Pharmacol. 1997; 75:295-298.
21. 2+-ATPase activation in platelet membranes of essential hypertensives and normotensives. Am J Physiol. 1990; 258:C988-C994.
22. Resink TJ, Tkachuk VA, Erne P, Buhler FR. Platelet membrane calmodulin-stimulated calcium adenosine triphosphatase altered activity in essential hypertension. Hypertension. 1986; 8:159-166.
23. Lindner A, Kenny M, Meacham AJ. Effects of a circulating factor in patients with essential hypertension on intracellular free calcium in normal platelets. N Engl J Med. 1987; 316:509-513.
24. Hollister MS, Menshikov M, Devyatova O. Humoral factor, intraplatelet calcium, and hypertension. Am J Hypertens. 1992; 5:131S-134S.
25. 2+-pump. J Biol Chem. 1995; 270:12184-12190.